BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 25822095)

  • 1. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of rheumatoid arthritis-associated interstitial lung disease.
    Chen J; Doyle TJ; Liu Y; Aggarwal R; Wang X; Shi Y; Ge SX; Huang H; Lin Q; Liu W; Cai Y; Koontz D; Fuhrman CR; Golzarri MF; Liu Y; Hatabu H; Nishino M; Araki T; Dellaripa PF; Oddis CV; Rosas IO; Ascherman DP
    Arthritis Rheumatol; 2015 Jan; 67(1):28-38. PubMed ID: 25302945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers in rheumatoid arthritis-associated interstitial lung disease.
    Wang T; Zheng XJ; Ji YL; Liang ZA; Liang BM
    Clin Exp Rheumatol; 2016; 34(4):587-91. PubMed ID: 27213221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
    Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).
    Yu M; Guo Y; Zhang P; Xue J; Yang J; Cai Q; You X; Ma J; Yang D; Jia Y; Wang Y; Li F; Chi S; Cao M; Chen J; Liu X
    Immunobiology; 2019 Jul; 224(4):551-559. PubMed ID: 31072629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
    Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
    Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease.
    Oka S; Furukawa H; Shimada K; Hashimoto A; Komiya A; Fukui N; Tsuchiya N; Tohma S
    BMC Musculoskelet Disord; 2017 Jan; 18(1):21. PubMed ID: 28103855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis.
    Yu R; Liu X; Deng X; Li S; Wang Y; Zhang Y; Ke D; Yan R; Wang Q; Tian X; Li M; Zeng X; Hu C
    Front Immunol; 2023; 14():1211790. PubMed ID: 37662936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.
    Matsuo T; Hashimoto M; Ito I; Kubo T; Uozumi R; Furu M; Ito H; Fujii T; Tanaka M; Terao C; Kono H; Mori M; Hamaguchi M; Yamamoto W; Ohmura K; Morita S; Mimori T
    Scand J Rheumatol; 2019 Mar; 48(2):87-94. PubMed ID: 30269670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
    Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.
    Doyle TJ; Dellaripa PF; Batra K; Frits ML; Iannaccone CK; Hatabu H; Nishino M; Weinblatt ME; Ascherman DP; Washko GR; Hunninghake GM; Choi AMK; Shadick NA; Rosas IO
    Chest; 2014 Jul; 146(1):41-50. PubMed ID: 24305643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers.
    Lucchino B; Di Paolo M; Gioia C; Vomero M; Diacinti D; Mollica C; Alessandri C; Diacinti D; Palange P; Di Franco M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of rheumatoid arthritis-associated interstitial lung disease.
    Wang T; Zheng XJ; Liang BM; Liang ZA
    Sci Rep; 2015 Oct; 5():14897. PubMed ID: 26443305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.